Recent Articles from GlobeNewswire

First quarter 2026 GAAP net income of $4.3 million or $0.32 per basic weighted average common share and Distributable Earnings(1) of $4.7 million or $0.35 per basic weighted average common share

HOUSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space technology and infrastructure services company, today announced its financial results for the first quarter ended March 31, 2026.

OMAHA, NE, May 14, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2026.

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Fiserv, Inc. (NASDAQ: FISV), a global leader in payments and financial technology solutions, today announced a new effort with OpenAI aimed at modernizing how financial institutions operate in the new age of AI.

WASHINGTON, May 14, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the findings of its third annual Hospital Operations Outlook Survey, which found that 92% of hospital leaders are anticipating major or moderate effects on their financial performance over the next decade as affordability concerns intensify, federal policy shifts take hold and care continues to move beyond the hospital setting.

PURCHASE, N.Y., May 14, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that a second philanthropic donation has been received from a participant in the ongoing expanded access program (EAP) for people with dementia with Lewy bodies (DLB). The ongoing EAP has been extended to provide two years of treatment for participants, thanks to a generous new donation from Mr. Jeffrey Pechter, founding partner of Mindful Capital in Delray Beach, FL.

, May 14, 2026 (GLOBE NEWSWIRE) -- AUSTIN, Texas – May 14, 2026 – EDAP TMS S.A. (Nasdaq: EDAP) today announced that it has entered into a letter of intent with Telix Pharmaceuticals Limited (“Telix”) to explore joint clinical research activities and physician education focused on the combination of EDAP’s Focal One Robotic HIFU and Telix’s PSMA PET imaging products in the management of prostate cancer.

Antwerp, Belgium, May 14, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced that members of the management team will participate in the following upcoming industry and investor conferences:

NEW YORK and LVIV, Ukraine, May 14, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, a clinical-stage biopharmaceutical company pioneering off-the-shelf allogeneic iNKT cell therapies for cancer and immune disorders, and First Lviv Territorial Medical Union today announced the initiation of a randomized Phase 2 clinical trial evaluating agenT-797, MiNK’s off-the-shelf allogeneic invariant natural killer T cell therapy (iNKTs), in patients with severe acute lung injury (ALI). The study has received authorization from the Ministry of Health of Ukraine and is supported by an active U.S. IND.

Company Introduces Condor, Merlin’s first product, bringing Merlin Pilot to large, multi-crew aircraft for civil and defense missions

WALTHAM, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven advanced therapy CDMO and gene editing services partner, today announced data from presentations at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting, held May 11-15 in Boston, MA. The data span multiple gene editing modalities, AI-powered protein discovery and optimization, and proprietary lipid nanoparticle (LNP) delivery, collectively demonstrating the strength of ElevateBio’s technologies and gene editing discovery services.

Fort Lee, NJ, May 14, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that management will participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ on Tuesday, May 19, 2026 in New York.

Expected to expand Intuitive Machine’s integrated space-to-Earth network, increasing capacity for deep space communications, data relay, and Position Navigation and Timing (PNT) capabilities 

Announced Positive 12-month Follow-on Data for Iopofosine I 131 in relapsed/refractory Waldenström Macroglobulinemia (r/r WM) 

Preconditioning-free (PC-free) 6-to-9-month clinical data with a single infusion of the lowest dose of rese-cel in the RESET-PV® study presented today at ASGCT 2026 Annual Meeting along with initial rese-cel translational data using Cellares’ industrialized, automated manufacturing

Rockville, Md., May 14, 2026 (GLOBE NEWSWIRE) -- Communication difficulties are one of the hallmarks of dementia, and they can be among the more challenging everyday aspects for caregivers.

NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced financial results for the first quarter ended March 31, 2026, and recent business highlights.

Company Reports Record $8.8M Net Income and $19.5M Adjusted EBITDA(8)

Purchase now opens door to initiate sale-leaseback discussions with interested parties.

SINGAPORE, May 14, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for AI and Bitcoin mining infrastructure, today released its unaudited financial results for the first quarter ended March 31, 2026.

Introducing Pear Drop Margarita & Fizzy Toffee Apple Martini

Foralumab is the first intranasal immune modulator in clinical trials for patients with Multiple System Atrophy

Company to Webcast Conference Call Live at 9:00 a.m. ET

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Summit Royalties Ltd (TSX-V: SUM; OTCQX: SUMMF), a precious metals streaming and royalty company, has qualified to trade on the OTCQX® Best Market. Summit Royalties Ltd upgraded to OTCQX from the OTCQB® Venture Market.

CMP-002 administration resulted in a statistically significant improvement in seizure phenotypes and parameters in a SYNGAP1 haploinsufficient mouse model

WELLESLEY HILLS, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced an upcoming presentation on its budoprutug program at the European Hematology Association (EHA) 2026 Congress, which will be held in Stockholm, Sweden June 11-14, 2026.

DUBLIN, May 14, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today reported financial results for the quarter ended March 31, 2026, and provided a business update.

Updated micvotabart pelidotin (MICVO) Phase 1 monotherapy data in 2L+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) on track for mid-year 2026; update to include analyses focused on patients treated at or below a dose cap

Record Quarterly Revenues of $1.04 Billion, a 105% Increase from a Year Ago

Company to explore the potential of integrating TULSA-PRO with PSMA PET molecular imaging technologies to enhance ablation planning and monitoring

(All amounts in release are in Canadian dollars)

A single infusion of the lowest dose of rese-cel administered without preconditioning, after discontinuation of all immunomodulators, demonstrated compelling drug-free responses for 6 months in 2 of 4 refractory patients; next dose cohort actively enrolling

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX: ILLM, OTCQB: ILLMF), in partnership with Cint Group AB (publ) (STO: CINT), a global technology platform for continuous research and measurement, is bringing self-serve brand lift measurement directly into the campaign setup. This enables marketers to launch studies up to 90% faster and see results in minutes instead of weeks, so they can act on insights while campaigns are live.

NOVATO, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Cyclarity Therapeutics, Inc., a clinical stage biopharmaceutical company engineering cyclodextrin molecules into simple, scalable, and affordable therapies that bind and remove toxic targets to address root causes of age-related disease, has just unveiled data from a clinical trial of its lead candidate, UDP-003 at the American Heart Association Vascular Discovery Scientific Sessions.

Operational Highlights for the First Quarter of 2026

ATLANTA, May 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three-month period ended April 4, 2026.

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B)(TSX:ABX) announced that the nominees listed in the Information Circular for the 2026 Annual Meeting of Shareholders were elected as directors of Barrick.

Bitcoin.com becomes the first platform to deploy Dinari’s embedded trading application, integrating dShares™ directly into its user experience

RICHMOND, Va., May 14, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will participate in the following upcoming investor conferences:

Company Reaffirms Annual Guidance; New Product Innovation Supports Improving Sales Trends Exiting the Quarter

FRAUENFELD, Switzerland, May 14, 2026 (GLOBE NEWSWIRE) -- Aebi Schmidt Group (NASDAQ: AEBI) (“Aebi Schmidt”, the “Group”, or the “Company”), a world-class specialty vehicles leader, reports strong order momentum and increased adjusted EBITDA.

Multi-year partnership brings award-winning THC margaritas to iconic music destinations across the country

LONDON and GAITHERSBURG, Md., May 14, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announces its operational and financial results for the first quarter ended March 31, 2026.

Designed to help financial institutions safely deploy and scale AI agents 

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced PRINCE SILVER CORP (CSE: PRNC; OTCQX: PRNCF), a silver exploration company, has qualified to trade on the OTCQX® Best Market. PRINCE SILVER CORP upgraded to OTCQX from the OTCQB® Venture Market.

WILMINGTON, Del., May 14, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that it will release its first quarter 2026 financial results before the market opens on Monday, May 18, 2026 via press release, which will be available on the Company’s website at https://ir.nrxpharma.com/. The Company will host a conference call at 8:00am ET the same day.

SINGAPORE, May 14, 2026 (GLOBE NEWSWIRE) -- Concorde International Group Ltd. (NASDAQ: YOOV) (the "Company"), an integrated provider of technology-enabled security solutions announced that it had been awarded multi-year contracts with a total value exceeding US$10 million. These agreements cover the delivery of integrated security solutions and services across industrial zones, business districts and community precincts in Singapore.

CELIA did not meet its primary endpoint assessing dose response; based on the strength of the biomarker and efficacy data, Biogen plans to advance diranersen to registrational development

BROOKFIELD, NEWS, May 14, 2026 (GLOBE NEWSWIRE) -- Brookfield Wealth Solutions (NYSE, TSX: BNT) today announced financial results for the three months ended March 31, 2026.

Distributable Earnings increased to $1.6 billion

Transaction in Own Shares

(1)   Non-GAAP measure. For more information, see the section entitled, “NON-GAAP MEASURES.”(2)   AISC excludes share-based compensation costs.(3)   Site-level AISC includes corporate G&A allocation and excludes remaining corporate G&A, share-based compensation costs and corporate-level sustaining capital expenditures.(4)   Excludes the $86.8 million 2025 cash income tax payment.

~ Achieved First Quarter 2026 Total Net Revenues of $15.1 Million, Up 73% Year Over Year ~

COCONUT CREEK, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (the “Company”), the leading lessor of commercial aircraft engines and global provider of aviation services, announced today the pricing of its public offering (the “Notes Offering”) of $200.0 million aggregate principal amount of 2.50% convertible senior notes due 2031 (the “Notes”), for total net proceeds of approximately $193.1 million, after deducting underwriting discounts and other estimated offering expenses. The offering size was increased from the previously announced offering size of $175.0 million. The Company also granted the underwriters of the Notes a 30-day option to purchase up to an additional $30.0 million principal amount of Notes, solely to cover over-allotments, if any. The Company currently intends to use the net proceeds from the issuance of the Notes to temporarily repay amounts outstanding under the Company’s revolving credit facility until deployed for general corporate purposes. The Notes Offering is expected to close on May 18, 2026, subject to satisfaction of customary closing conditions.

New data demonstrate promising preclinical safety profile and durable LDL-C lowering of ≥90% with single dose of EDIT-401 in non-human primates through ~6 months

LAKEWOOD, NJ, May 14, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: EZRA) (“Reliance”, “we” or the “Company”) today announced that the Company’s Board of Directors approved a 1-for-40 reverse stock split (the “Reverse Stock Split”) of the Company’s common stock (the “Common Stock”) in order to regain compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market (Rule 5550(a)(2)). The Company was not required to obtain shareholder approval to effectuate the Reverse Stock Split. The Company filed articles of amendment to the Company’s articles of restatement to the articles of incorporation with the Florida Department of State, Division of Corporations which is expected to become effective as of 5:00 p.m. Eastern Time on May 15, 2026.  The Common Stock will begin trading on The Nasdaq Capital Market on a reverse split-adjusted basis at the start of trading on May 18, 2026, under the symbol “EZRA” and under a new CUSIP number, 75946W 504.

Sustained Focus on Execution as Transformation Progresses

Company completes $22 million network build to boost connectivity for fans at soccer’s biggest event

Issued on behalf of QSE — Quantum Secure Encryption Corp.

Shell plc – Report on Payments to Governments for the year 2025

Issued on behalf of GoldHaven Resources Corp.

Commerce veteran Lawrence Roycroft joins as Vice President for EMEA, as KIBO reports accelerating net-new bookings growth, expanded customer base, and deepened partner ecosystem across the region

PARIS and BRATISLAVA, Slovakia, May 14, 2026 (GLOBE NEWSWIRE) -- ESET, a leader in cybersecurity solutions and services, today announced an integration of ESET with Sekoia, a leading provider of detection and response solutions, to enhance the security resiliency of organizations.

MONTREAL and BRATISLAVA, Slovakia, May 14, 2026 (GLOBE NEWSWIRE) -- ESET Research uncovered new activities from Belarus-aligned threat group FrostyNeighbor, targeting governmental organizations in Ukraine. FrostyNeighbor has been running continual cyberoperations, changing and updating its toolset regularly and updating its compromise chain and methods to evade detection — targeting victims located in Eastern Europe, according to ESET telemetry. The ultimate aim of the attacks is espionage.

LONDON, May 14, 2026 (GLOBE NEWSWIRE) -- Sage (FTSE: SGE), a leader in accounting, financial, HR and payroll technology for small and medium-sized businesses, today announced the appointments of Krish Vitaldevara as Chief Product Officer and Anand Swaminathan as Chief Strategy Officer. 

PARIS, FRANCE, 14 May 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today the presentation of the Phase II LANTIC trial for the first aesthetic glabellar lines indication with corabotase, a custom-designed molecule recognized as the first in a newly designated class at the SCALE 2026 symposium on May 16, 2026. The Phase I/II trial evaluates the safety and efficacy of corabotase in three aesthetic indications of moderate to severe upper facial lines: glabellar lines, forehead lines and lateral canthal lines.

Decade-long partnership established to connect data and power governed AI to accelerate smarter decisions

SHANGHAI, May 14, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, and Shanghai Tenry Pharmaceutical Co., Ltd. (“Tenry Pharmaceutical”) have entered into a strategic partnership at the 92nd PHARMCHINA in Shanghai, marking a significant step toward advancing AI-powered chronic disease management and broader support across the patient journey.

LOS ANGELES, May 13, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Atara Biotherapeutics, Inc. (“Atara” or “the Company”) (NASDAQ: ATRA) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

New location brings FDH’s Hardware and Electronics teams together to strengthen supply chain support for India’s growing aerospace and defense market

LOS ANGELES, May 13, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Willis Towers Watson Public Limited Company (“Willis Towers Watson” or “the Company”) (NASDAQ: WTW) for violations of the securities laws.